Targeting Notch, IL-1 and Leptin crosstalk may have promising approach in HCT-15 colorectal cancer cells


Erkasap N., Erten Yücel Z., Gültekin A., Özkurt M.

American Society for Biochemistry and Molecular Biology (ASBMB) Annual Meeting, Texas, United States Of America, 23 March 2024, pp.1, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • City: Texas
  • Country: United States Of America
  • Page Numbers: pp.1
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Abnormal expression/activation of Notch is associated with cancer development (Guo et al.,

2011). Notch activity is specifically increased in tumor endothelium and in various tumor types.

Since the Notch signaling pathway can mediate communication between various cell types in

the tumor microenvironment, interactions between tumor cells and endothelial cells can promote

angiogenesis (Rehman AO 2006). The levels of IL-1α/-β ligands, which are components of the

IL-1 system, are increased in breast cancer. In studies conducted in breast cancer cells, leptin

increased the mRNA and protein levels of all components of the IL-1 system (Gonzalez-Perez

RR 2010).Leptin is a cytokine secreted by adipocytes and cancer cells that promotes

angiogenesis. Increased leptin signaling is associated with the expression of proteins and is

implicated in cancer progression and tumor angiogenesis (Gonzalez-Perez et al., 2013). An

interaction between Notch, leptin and IL-1 signaling (NILCO) affects the expression of

pro-angiogenic molecules, leading to cell proliferation and migration of breast cancer cells (Guo

and Gonzalez-Perez, 2011). Leptin signaling has been shown to regulate VEGF/VEGFR-2,

Notch and its targets in breast cancer (Guo and Gonzalez-Perez, 2011). In addition, leptin may

contribute to angiogenesis, migration and proliferation through its induction (Ruben Rene

Gonzalez-Perez 2013).In this study, we aimed to show the interactions of NILCO signaling

pathways with each other as a result of the inhibition of each of them separately and their

MMP-related contributions on angiogenesis, migration and proliferation. For this purpose, we

tried to explain the mechanisms of action on angiogenic molecules, cell proliferation and

migration by inhibiting NILCO-related genes in the human colorectal cancer (CRC) cell line

HCT-15.